Viking Therapeutics stock is jumping Thursday afternoon after the biotech company reported third quarter results that topped analyst expectations. Wall Street currently holds 13 Buy ratings on the name.

Market Domination Co-Hosts Julie Hyman and Josh Lipton break down the details.

To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

This post was written by Angel Smith